Efficacy of antiepileptic drugs for the treatment of Dravet syndrome with different genotypes

Bromide is most effective and is a well-tolerated drug among DS patients, especially among SCN1A-negative patients. Carbamazepine should be avoided in patients with SCN1A mutations.